---
figid: PMC9343382__41401_2021_838_Fig1_HTML
figtitle: 'Reduced nicotinamide adenine dinucleotide phosphate in redox balance and
  diseases: a friend or foe?'
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC9343382
filename: 41401_2021_838_Fig1_HTML.jpg
figlink: /pmc/articles/PMC9343382/figure/Fig1/
number: F1
caption: NAD+synthesis via salvage pathway using NAM or NR, de novo pathway using
  tryptophan and preiss-handler pathway using NA as the precursors. NAD+, nicotinamide
  adenine dinucleotide, NAM, nicotinamide; NMN, nicotinamide mononucleotide; NR, nicotinamide
  riboside; NRK, NR kinase; NA, nicotinic acid; TDO, tryptophan 2,3-dioxygenase; IDO,
  indoleamine 2,3-dioxygenase; KFase, kynurenine formamidase; K3H, kynurenine‐3‐hydroxylase;
  AMS, 2‐amino‐3‐muconate‐semialdehyde; ACMS, 2‐amino‐3‐carboxy‐muconate‐semialdehyde;
  ACMSD, ACMS decarboxylase; NAMN, nicotinic acid mononucleotide; QPRT, quinolinate
  phosphoribosyltransferase; PRPP, phosphoribosyl pyrophosphate; NAAD, nicotinic acid
  adenine dinucleotide; NAPRT, nicotinic acid phosphoribosyltransferase; NMNAT, nicotinamide
  mononucleotide adenylyltransferase; NADSYN, NAD+ synthetases.
papertitle: 'Reduced nicotinamide adenine dinucleotide phosphate in redox balance
  and diseases: a friend or foe?.'
reftext: Nirmala Koju, et al. Acta Pharmacol Sin. 2022 Aug;43(8):1889-1904.
year: '2022'
doi: 10.1038/s41401-021-00838-7
journal_title: Acta Pharmacologica Sinica
journal_nlm_ta: Acta Pharmacol Sin
publisher_name: Springer Nature Singapore
keywords: aging | Alzheimer’s disease | Parkinson’s disease | diabetes | obesity |
  cancer
automl_pathway: 0.9003767
figid_alias: PMC9343382__F1
figtype: Figure
redirect_from: /figures/PMC9343382__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9343382__41401_2021_838_Fig1_HTML.html
  '@type': Dataset
  description: NAD+synthesis via salvage pathway using NAM or NR, de novo pathway
    using tryptophan and preiss-handler pathway using NA as the precursors. NAD+,
    nicotinamide adenine dinucleotide, NAM, nicotinamide; NMN, nicotinamide mononucleotide;
    NR, nicotinamide riboside; NRK, NR kinase; NA, nicotinic acid; TDO, tryptophan
    2,3-dioxygenase; IDO, indoleamine 2,3-dioxygenase; KFase, kynurenine formamidase;
    K3H, kynurenine‐3‐hydroxylase; AMS, 2‐amino‐3‐muconate‐semialdehyde; ACMS, 2‐amino‐3‐carboxy‐muconate‐semialdehyde;
    ACMSD, ACMS decarboxylase; NAMN, nicotinic acid mononucleotide; QPRT, quinolinate
    phosphoribosyltransferase; PRPP, phosphoribosyl pyrophosphate; NAAD, nicotinic
    acid adenine dinucleotide; NAPRT, nicotinic acid phosphoribosyltransferase; NMNAT,
    nicotinamide mononucleotide adenylyltransferase; NADSYN, NAD+ synthetases.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - STAC3
  - NAMPT
  - ATP8A2
  - NRK
  - NMNAT1
  - NAPRT
  - QPRT
  - DLX3
  - TDO2
  - IDO1
  - ACMSD
  - TWIST2
  - nr
  - ATPsynbeta
  - Atpalpha
  - Nrk
  - Nmnat
  - Nadsyn
  - Naprt
  - na
  - de
  - KFase
  - ams
  - NAMPT
  - ATP
  - NAD
  - NADSYN
  - quinolinic acid
  - tryptophan
  - N-formylkynurenine
  - kynurenine
  - picolinic acid
  - 3-hydroxyl-kynurenine
  - CO,+H
  - O+ATP
---
